US7469641051
US7469641051
Q32 Bio Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 248.28M EUR | 302.4M EUR | 93.92M EUR | 42.69M EUR |
Enterprise Value | 139.86M EUR | 201.43M EUR | 56.82M EUR | 9.74M EUR |
Valuation Multiples | ||||
Trailing P/E | 2.65x | 8.95x | 2.83x | 1.04x |
Forward P/E | -8.18x | -- | -- | -- |
Price to Sales | 4.62x | 5.63x | 1.75x | 0.79x |
Price to Book | 1.87x | 2.86x | 2.03x | 1.02x |
EV/Revenue | 2.6x | 3.75x | 1.06x | 0.18x |
EV/EBITDA | 6.41x | 5.84x | 1.66x | 0.23x |
Price to FCF (P/FCF) | 12.8x | -- | -- | -- |
EV/FCF | 7.21x | -- | -- | -- |
FCF Yield | 7.81% | -6.56% | -29.18% | -49.34% |